Articles

An international research collaboration led by the University of Cambridge analysed existing cohort studies and randomised trials on coronary risk and fatty acid intake. They showed that current evidence does not support guidelines which restrict the consumption of saturated fats in order to prevent heart disease….

Patients with diabetic foot ulcers have an annual burden on yearly Medicare of $11,710…. 

An analysis of 25 population studies which focused on weight and included 4 million women, 16,000 of whom developed ovarian cancer. The report showed a dose-response relationship: a six percent increased risk of developing ovarian cancer for every 5-point increase in BMI….

Taking omega-3 fatty-acid supplements for nearly five years failed to reduce the incidence of CVD mortality, MI, stroke, unstable angina, revascularization, CHF hospitalizations, and resuscitated cardiac arrest, report investigators….

New evidence suggests that increased intake of certain vitamins, including B vitamins, may play a role in the increased prevalence of obesity in recent years….

Although glucagon-like peptide-1 (GLP-1) is highly biologically active following intravenous or subcutaneous injection, a non-injectable alternative for activating GLP-1 receptor signaling would clearly be desirable. Studies by Gutniak, Ahren and colleagues in Sweden have shown that GLP-1 formulated in buccal tablets is absorbed into the circulation and lowers blood glucose …

Research showed type 2 diabetes patients who took once-weekly albiglutide attained significant reductions in A1C, comparable with those who were on once-daily liraglutide. "The data indicate that albiglutide is a reasonable alternative to other glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of diabetes. Researchers said that, "It has good …

When finalized, the World Health Organization guideline will provide countries with recommendations on limiting the consumption of sugars to reduce public health problems like obesity and tooth decay. For information on how to submit comments, see below…. 

Italian researchers report that polydeoxyribonucleotide (PDRN), an adenosine receptor A2A agonist, shows some efficacy in healing chronic diabetic foot ulcers….

In the largest study to date of the genetic basis of the disease, DNA data was brought together from more than 48,000 patients and 139,000 healthy controls from four different ethnic groups….